Lack of Replication of the GRIN2A-by-Coffee Interaction in Parkinson Disease

PLoS Genetics

Volumn 10, Issue 11, 2014, Pages

  Ahmed, Ismaïl ^a,b   Lee, Pei Chen ^c   Lill, Christina M ^d,e   Searles Nielsen, Susan ^f   Artaud, Fanny ^a,g   Gallagher, Lisa G ^f   Loriot, Marie Anne ^h,i   Mulot, Claire ^i,j   Nacfer, Magali ^i,j   Liu, Tian ^k   Biernacka, Joanna M ^l   Armasu, Sebastian ^l   Anderson, Kari ^l   Farin, Federico M ^f   Funch Lassen, Christina ^m   Hansen, Johnni ^m   Olsen, Jørgen H ^m   Bertram, Lars ^d,n   Maraganore, Demetrius M ^o   Checkoway, Harvey ^p   Ritz, Beate ^q   Elbaz, Alexis ^a,g   more..

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f UNIVERSITY OF WASHINGTON   (United States)

^g INSERM   (France)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j Centre de ressources biologiques (CRB) Epigenetec   (France)

^k MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

^l MAYO CLINIC   (United States)

^m DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

ⁿ IMPERIAL COLLEGE LONDON   (United Kingdom)

^o NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; CAFFEINE; COFFEE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A;

ADULT; AGED; ARTICLE; COFFEE; CONTROLLED STUDY; FLUID INTAKE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; GRIN2A GENE; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; ADVERSE EFFECTS; DENMARK; DNA REPLICATION; DRUG EFFECTS; GENETICS; GENOTYPE; METABOLISM; MORTALITY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

CAFFEINE; COFFEE; DENMARK; DNA REPLICATION; GENE-ENVIRONMENT INTERACTION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, N-METHYL-D-ASPARTATE; SMOKING;

EID: 84912099083     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004788     Document Type: Article

References (29)

1. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747–753.
2. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, et al. (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet 8: e1002548.
3. Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, et al. (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72: 893–901.
4. Qi H, Li S, (2013) Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease. Geriatr Gerontol Int 1–10.
5. Shook BC, Jackson PF, (2011) Adenosine A(2A) Receptor Antagonists and Parkinson's Disease. ACS Chem Neurosci 2: 555–567.
6. Kraft P, Yen Y-C, Stram DO, Morrison J, Gauderman WJ, (2007) Exploiting gene-environment interaction to detect genetic associations. Hum Hered 63: 111–119.
7. Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, et al. (2011) Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet 7: e1002237.
8. Thomas D, (2010) Gene–environment-wide association studies: emerging approaches. Nat Rev Genet 11: 259–272.
9. Thomas DC, Lewinger JP, Murcray CE, Gauderman WJ, (2012) Invited commentary: GE-Whiz! Ratcheting gene-environment studies up to the whole genome and the whole exposome. Am J Epidemiol 175: 203–207.
10. Amin N, Byrne E, Johnson J, Chenevix-Trench G, Walter S, et al. (2012) Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry 17: 1116–1129.
11. Yang Q, Khoury MJ, Flanders WD, (1997) Sample size requirements in case-only designs to detect gene-environment interaction. Am J Epidemiol 146: 713–720.
12. Mukherjee B, Chatterjee N, (2008) Exploiting gene-environment independence for analysis of case-control studies: an empirical Bayes-type shrinkage estimator to trade-off between bias and efficiency. Biometrics 64: 685–694.
13. Wermuth L, Lassen CF, Himmerslev L, Olsen J, Ritz B, (2012) Validation of hospital register-based diagnosis of Parkinson's disease. Dan Med J 59: A4391.
14. Morimoto LM, White E, Newcomb PA, (2003) Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol 158: 259–263.
15. Witte JS, Gauderman WJ, Thomas DC, (1999) Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am J Epidemiol 149: 693–705.
16. Wang Y, Localio R, Rebbeck TR, (2006) Evaluating bias due to population stratification in epidemiologic studies of gene-gene or gene-environment interactions. Cancer Epidemiol Biomarkers Prev 15: 124–32.
17. Fayard C, Bonaventure A, Benatru I, Roze E, Dumurgier J, et al. (2011) Impact of recommendations on the initial therapy of Parkinson's disease: a population-based study in France. Parkinsonism Relat Disord 17: 543–546.
18. Bower JH, Maraganore DM, McDonnell SK, Rocca WA, (1999) Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology 52: 1214–1220.
19. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT, et al. (2002) Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155: 732–738.
20. Searles Nielsen S, Checkoway H, Butler RA, Nelson HH, Farin FM, et al. (2012) LINE-1 DNA methylation, smoking and risk of Parkinson's disease. J Parkinsons Dis 2: 303–308.
21. Maraganore DM, de Andrade M, Lesnick TG, Strain KJ, Farrer MJ, et al. (2005) High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 77: 685–693.
22. Facheris MF, Schneider NK, Lesnick TG, de Andrade M, Cunningham JM, et al. (2008) Coffee, caffeine-related genes, and Parkinson's disease: a case-control study. Mov Disord 23: 2033–2040.
23. Searles Nielsen S, Franklin GM, Longstreth WT, Swanson PD, Checkoway H, (2013) Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol 74: 472–477.
24. Gauderman WJ, (2002) Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155: 478–484.
25. Huberman M, Langholz B, (1999) Re: “Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies”. Am J Epidemiol 150: 219–220.
26. Moreno V, Martín ML, Bosch FX, de Sanjosé S, Torres F, et al. (1996) Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies. Am J Epidemiol 143: 293–300.
27. Botto LD, Khoury MJ, (2001) Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 153: 1016–1020.
28. Tchetgen Tchetgen EJ, Kraft P, (2011) On the robustness of tests of genetic associations incorporating gene-environment interaction when the environmental exposure is misspecified. Epidemiology 22: 257–261.
29. Weinberg CR, (1986) Applicability of the simple independent action model to epidemiologic studies involving two factors and a dichotomous outcome. Am J Epidemiol 123: 162–173.